Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy

The integrated in silico design, chemical synthesis, biological screening and molecular mechanism studies as an efficient strategy for discovery PLK1/EEF2K dual inhibitors in breast cancer therapy.210